Home Cart Sign in  
Chemical Structure| 1801530-11-9 Chemical Structure| 1801530-11-9

Structure of 1801530-11-9

Chemical Structure| 1801530-11-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IKE is a potent, metabolically stable inhibitor of system Xc- and inducer of ferroptosis .

Synonyms: Imidazole Ketone Erastin; PUN30119; IKE

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Kato, Kazuhiro ; Yasui, Hironobu ; Sato-Akaba, Hideo ; Emoto, Miho C ; Fujii, Hirotada G ; Kmiec, Maciej M , et al.

Abstract: Targeting ferroptosis, cell death caused by the iron-dependent accumulation of lipid peroxides, and disruption of the redox balance are promising strategies in cancer therapy owing to the physiological characteristics of cancer cells. However, the detection of ferroptosis using in vivo imaging remains challenging. We previously reported that redox maps showing the reduction power per unit time of implanted tumor tissues via non-invasive redox imaging using a novel, compact, and portable electron paramagnetic resonance imaging (EPRI) device could be compared with tumor tissue sections. This study aimed to apply the EPRI technique to the in vivo detection of ferroptosis. Notably, redox maps reflecting changes in the redox status of tumors induced by the ferroptosis inducing agent imidazole ketone erastin (IKE) were compared with the immunohistochemical images of 4-hydroxynonenal (4-HNE) in tumor tissue sections. Our comparison revealed a negative correlation between the reducing power of tumor tissue and the number of 4-HNE-positive cells. Furthermore, the control and IKE-treated groups exhibited significantly different distributions on the correlation map. Therefore, redox imaging using EPRI may contribute to the non-invasive detection of ferroptosis in vivo.

Keywords: Electron paramagnetic ; resonance imaging ; Redox imaging ; tumor redox status ; ferroptosis ; cancer therapy ; Imidazole ketone erastin ; GPX4 ; lipid peroxidation

Purchased from AmBeed:

Alternative Products

Product Details of IKE (Imidazole ketone erastin )

CAS No. :1801530-11-9
Formula : C35H35ClN6O5
M.W : 655.14
SMILES Code : O=C1N(C2=CC(C(CN3C=CN=C3)=O)=CC=C2OC(C)C)C(CN4CCN(C(COC5=CC=C(Cl)C=C5)=O)CC4)=NC6=C1C=CC=C6
Synonyms :
Imidazole Ketone Erastin; PUN30119; IKE
MDL No. :MFCD31813799
InChI Key :PSPXJPWGVFNGQI-UHFFFAOYSA-N
Pubchem ID :91824786

Safety of IKE (Imidazole ketone erastin )

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HT1080 cells 2 μM 10-14 hours To study IKE-induced lipid peroxidation and cell death, results showed that IKE significantly increased ROS accumulation and cell death. PMC11487270
HT-1080 150 nM 12 hours To evaluate erastin2-induced ferroptosis, results showed HT-1080 cells were sensitive to erastin2, with accumulation of lipid peroxides and decreased cell confluence. PMC11700874
H460 150 nM 12 hours To evaluate erastin2-induced ferroptosis, results showed H460 cells were resistant to erastin2, with no significant accumulation of lipid peroxides or decrease in cell confluence. PMC11700874
C6 150 nM 12 hours To evaluate erastin2-induced ferroptosis, results showed C6 cells were highly sensitive to erastin2, with significant accumulation of lipid peroxides and decreased cell confluence. PMC11700874
Rheumatoid arthritis synovial fibroblasts (RASFs) 1 μM 18 hours To evaluate the ferroptosis-inducing effect of IKE on synovial fibroblasts, results showed that IKE significantly increased lipid ROS accumulation. PMC8813949
LLC mouse lung carcinoma cell line 5 μM 24 hours MI-EXO suppressed erastin-induced lipid-ROS accumulation and ferroptosis PMC10040407
K7M2 mouse osteosarcoma cell line 20 μM 24 hours MI-EXO suppressed erastin-induced lipid-ROS accumulation and ferroptosis PMC10040407
NTC/T1 null cells 50 μM 24 hours To evaluate the inhibitory effect of IKE on the growth of LSCC organoids, it was found that ERO1α depletion significantly enhanced the inhibitory effect of IKE. PMC11015652
OS-RC-2 cells 2 μM 24-30 hours To study IKE-induced lipid peroxidation and cell death, results showed that IKE significantly increased ROS accumulation and cell death. PMC11487270
HT-1080 cells 0.5 μM 4 hours To study the mechanism of RSL3-induced ferroptosis PMC9809962
Calu-1 cells 0.5 μM 4 hours To study the mechanism of RSL3-induced ferroptosis PMC9809962
HepG2 cells 10 μM 4 hours Measure the level of ferroptosis and analyze the expression of RB1CC1 and related proteins PMC8882240
A549 cells 1 μM 4 hours Evaluate the effect of drugs on stimulating RB1CC1 nuclear translocation PMC8882240
T24 cells 2 μM 48 hours USP52-depleted T24 cells exhibited heightened sensitivity to Erastin-induced ferroptosis PMC11615784
HEK293T cells 25 nM 60 hours Identified USP52 as a key regulator of xCT protein levels PMC11615784
LLC 20 μM To evaluate the inhibitory effect of IKE on LLC cell activity, the results showed that cell viability was reduced to 45% at 20 μM concentration. PMC10754143
A549 20 μM To evaluate the inhibitory effect of IKE on A549 cell activity, the results showed that cell viability was reduced to 52% at 20 μM concentration. PMC10754143
H1299 20 μM To evaluate the inhibitory effect of IKE on H1299 cell activity, the results showed that cell viability was reduced to 52% at 20 μM concentration. PMC10754143
GBM cells 5 µM GBM cells exhibit high resistance to IKE-induced ferroptosis, but co-treatment with IKE and DHAA significantly enhances their sensitivity. PMC10522586
PCa cells 2 µM PCa cells exhibit high resistance to IKE-induced ferroptosis, but co-treatment with IKE and DHAA significantly enhances their sensitivity. PMC10522586
Human aortic smooth muscle cells (HASMCs) 2 μM IKE induced ferroptosis in HASMCs, and overexpression of METTL3 accelerated IKE-induced ferroptosis, while knockdown of METTL3 inhibited IKE-induced ferroptosis. PMC9274489

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse Xenograft tumor model 30 mg/kg Not used MI significantly reduced the sensitivity of tumors to erastin or IKE-induced ferroptosis PMC10040407
Nude mice OS-RC-2 tumor model intraperitoneal injection 40 mg/kg every other day for 12 days To study the inhibitory effect of IKE on tumor growth, results showed that IKE significantly inhibited tumor growth, and the effect was enhanced when combined with SAM. PMC11487270
DBA/1 mice Collagen-induced arthritis (CIA) model Intraperitoneal injection 40 mg/kg Once daily for 22 days To evaluate the alleviating effect of IKE on joint inflammation and destruction in CIA model mice, results showed that IKE significantly reduced synovial inflammation and accelerated inflammation resolution. PMC8813949
Nude mice HT-1080 cell xenograft model Intraperitoneal injection 40 mg/kg Once every other day for 2 weeks To evaluate the tumor suppression effect of IKE PMC9809962
BALB/c Nude mice Bladder cancer xenograft model Intraperitoneal injection 40 mg/kg Every other day for two weeks Combination of USP52 depletion and IKE treatment significantly inhibited bladder cancer progression PMC11615784
Nude mice LSCC PDX model Intraperitoneal injection 40 mg/kg Once every other day, continuous treatment To evaluate the inhibitory effect of combined ERO1α inhibition and IKE treatment on PDX tumor growth, it was found that the combined treatment significantly suppressed tumor growth. PMC11015652
rats C6 glioma model intravenous injection 25 mg/kg single dose, lasting 30 minutes To evaluate the inhibition of system xc- by IKE in the C6 glioma model, results showed IKE significantly reduced [18F]hGTS13 uptake, indicating effective inhibition of system xc-. PMC11700874
C57BL/6 mice LLC-luc lung cancer model IntratumOral injection 50 mg/kg Every three days, for a total of three injections To evaluate the efficacy of IKE combined with PDT in the LLC-luc lung cancer model, the results showed that the combination treatment significantly inhibited tumor growth, with an average tumor volume reduction of 88.0%. PMC10754143
C57BL/6J mice glioblastoma xenograft model intracerebroventricular injection 650 ng daily for 7 days Co-treatment with IKE and DHAA significantly reduced tumor size and prevented tumor invasion and migration, demonstrating its efficacy in inducing ferroptosis in vivo. PMC10522586
Mice BAPN-induced aortic dissection model Intraperitoneal injection 5 mg/kg Once every 2 days in the first week and once a day in the second and third weeks, lasting for 3 weeks Liproxstatin-1 significantly reduced the incidence and mortality of BAPN-induced aortic dissection and alleviated aortic degeneration. PMC9274489
BALB/c Nude mice ZR-75-1-TamR xenograft model Intraperitoneal injection 40 mg/kg Every three days until the end of the experiment IKE in combination with Tamoxifen significantly inhibited the growth of ZR-75-1-TamR tumors and reduced the levels of SLC7A11 and Ki67 in tumor tissues, while increasing the levels of 4-HNE. PMC11756422
C57BL/6 mice hypercholesterolemic mice induced by high-cholesterol diet (HCD) intraperitoneal injection 40 mg/kg every other day for 1 month To evaluate the effect of IKE on ferroptosis sensitivity of HSCs in hypercholesterolemic mice, the results showed that IKE significantly restored the maintenance and differentiation balance of HSCs. PMC10025135
Mice cell-derived xenograft (CDX) mouse models daily administration 50 mg/kg daily administration until the end of the experiment Evaluate the inhibitory effect of IKE on tumor growth PMC8882240

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.53mL

0.31mL

0.15mL

7.63mL

1.53mL

0.76mL

15.26mL

3.05mL

1.53mL

References

 

Historical Records

Categories